The role of NF-κB1A promoter polymorphisms on coronary artery disease risk

Nil Özbilüm1, Serdal Arslan, Öcal Berkan

  • 1Department of Molecular Biology and Genetics, Faculty of Science, Cumhuriyet University, Sivas, Turkey.

Insights

The NF-κBIA-826TT genotype is a significant risk factor for coronary artery disease (CAD) in the Turkish population. This finding may serve as a valuable marker for CAD development and prevention strategies.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Immunology

Background:

  • Coronary artery disease (CAD) is a leading global cause of mortality, recognized as a chronic inflammatory condition.
  • Nuclear factor kappa B (NF-κB) is a key regulator of immune responses.
  • NF-κB inhibitor alpha (NF-κBIA) plays a crucial role in modulating NF-κB activity.

Purpose of the Study:

  • To investigate the association between CAD and specific polymorphisms in the NF-κBIA gene (-297 C/T, -826 C/T, -881 A/G) within a Turkish population.
  • To determine if these NF-κBIA gene variants are risk factors for the development of CAD.

Main Methods:

  • Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was employed to analyze genotypes.
  • The study included 201 patients diagnosed with CAD and 201 healthy controls from Turkey.
  • Allele, genotype, and haplotype frequencies were compared between the case and control groups.

Main Results:

  • No significant differences were observed for NF-κBIA-297 C/T and -881 A/G polymorphisms between CAD patients and controls.
  • The NF-κBIA-826TT genotype frequency was significantly higher in CAD patients (p=0.015, adjusted OR=7.09).
  • The NF-κBIA-826T allele carriage rate was also significantly higher in CAD patients (p=0.03, OR=1.43).
  • Linkage analysis revealed close linkage among the three NF-κBIA variants, with specific haplotypes (TTG, TTA, TCG) associated with CAD risk.

Conclusions:

  • The NF-κBIA-826TT genotype is identified as a significant risk factor for CAD in the studied Turkish population.
  • This genotype may serve as a valuable genetic marker for predicting CAD development.
  • Further research into the functional implications of NF-κBIA variants in CAD pathogenesis is warranted.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...